Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/29955
Title: | PIGN encephalopathy: Characterizing the epileptology. | Austin Authors: | Bayat, Allan;de Valles-Ibáñez, Guillem;Pendziwiat, Manuela;Knaus, Alexej;Alt, Kerstin;Biamino, Elisa;Bley, Annette;Calvert, Sophie;Carney, Patrick W ;Caro-Llopis, Alfonso;Ceulemans, Berten;Cousin, Janice;Davis, Suzanne;des Portes, Vincent;Edery, Patrick;England, Eleina;Ferreira, Carlos;Freeman, Jeremy;Gener, Blanca;Gorce, Magali;Heron, Delphine;Hildebrand, Michael S ;Jezela-Stanek, Aleksandra;Jouk, Pierre-Simon;Keren, Boris;Kloth, Katja;Kluger, Gerhard;Kuhn, Marius;Lemke, Johannes R;Li, Hong;Martinez, Francisco;Maxton, Caroline;Mefford, Heather C;Merla, Giuseppe;Mierzewska, Hanna;Muir, Alison;Monfort, Sandra;Nicolai, Joost;Norman, Jennifer;O'Grady, Gina;Oleksy, Barbara;Orellana, Carmen;Orec, Laura Elena;Peinhardt, Charlotte;Pronicka, Ewa;Rosello, Monica;Santos-Simarro, Fernando;Schwaibold, Eva Maria Christina;Stegmann, Alexander P A;Stumpel, Constance T;Szczepanik, Elzbieta;Terczyńska, Iwona;Thevenon, Julien;Tzschach, Andreas;Van Bogaert, Patrick;Vittorini, Roberta;Walsh, Sonja;Weckhuysen, Sarah;Weissman, Barbara;Wolfe, Lynne;Reymond, Alexandre;De Nittis, Pasquelena;Poduri, Annapurna;Olson, Heather;Striano, Pasquale;Lesca, Gaetan;Scheffer, Ingrid E ;Møller, Rikke S;Sadleir, Lynette G | Affiliation: | The Florey Institute of Neuroscience and Mental Health Epilepsy Research Centre Medicine (University of Melbourne) Department of Neurosciences, Queensland Children's Hospital, South Brisbane, Queensland, Australia Royal Children's Hospital, Parkville, Victoria, Australia Institute for Regional Health Services, University of Southern Denmark, Odense, Denmark Department of Medicine, University of Melbourne, Parkville, Victoria, Australia Department of Epilepsy Genetics and Personalized Medicine, Danish Epilepsy Center, Dianalund, Denmark Department of Neuropediatrics, University Medical Center Schleswig-Holstein, Christian Albrecht University, Kiel, Germany Institute for Genomic Statistics and Bioinformatics, University Hospital Bonn, Rhenish Friedrich Wilhelm University of Bonn, Bonn, Germany Center for Human Genetics, Neu-Ulm, Germany University Children's Hospital, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany Genomics Unit, University and Polytechnic Hospital La Fe, Valencia, Spain Department of Pediatric Neurology, Antwerp University Hospital, Edegem, Belgium Section of Human Biochemical Genetics, National Human Genome Research Institute, Bethesda, Maryland, USA Department of Neuropediatrics, Lyon University Hospital, Lyon, France Department of Medical Genetics, University Hospital of Lyon, Lyon, France Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, Massachusetts, USA Department of Genetics, Cruces University Hospital, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain Institute of Clinical Molecular Biology, Christian Albrecht University of Kiel, Kiel, Germany Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, Warsaw, Poland Inserm U1209, Grenoble Alpes University Hospital Center, University of Grenoble Alpes, Grenoble, France Department of Genetics, Intellectual Disability and Autism Clinical Research Group, Pierre and Marie Curie University, Pitié-Salpêtrière Hospital, Public Hospital Network of Paris, Paris, France.. Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.. Center for Rare Diseases, University of Leipzig Medical Center, Leipzig, Germany Clinic for Pediatric Neurology, Hamburg, Germany Department of Child and Adolescent Neurology, Institute of Mother and Child, Warsaw, Poland Center for Pediatric Neurological Disease Research, Department of Cell and Molecular Biology, St, Jude Children's Research Hospital, Memphis, Tennessee, USA Department of Neurology, Maastricht University Medical Center, Maastricht, the Netherlands INTEGRIS Pediatric Neurology, Oklahoma City, Oklahoma, USA Starship Children's Hospital, Auckland, New Zealand Emory University School of Medicine, Atlanta, Georgia, USA Clinical Genetics, La Paz University Hospital, Madrid, Spain Institute of Human Genetics, Heidelberg University, Heidelberg, Germany Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands Department of Clinical Genetics and School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands Department of Genetics, University of Bourgogne-Franche Comté, Dijon, France Center for Child and Adolescent Medicine, Pediatric Neurology, Heidelberg University Hospital, Heidelberg, Germany Institute of Clinical Genetics, Dresden University of Technology, Dresden, Germany Neurology Department, University Hospital Antwerp, Antwerp, Belgium Angers University Hospital, Angers, France Department of Pediatrics, Regina Margherita Children's Hospital, Turin, Italy Applied and Translational Genomics Group, Center for Molecular Neurology, University of Antwerp, Antwerp, Belgium Epilepsy Genetics Program, Department of Neurology, Boston Children's Hospital, Boston, Massachusetts, USA.. Department of Medical Genetics, Children's Memorial Health Institute, Warsaw, Poland National Human Genome Research Institute, Bethesda, Maryland, USA Giannina Gaslini Institute, Genoa, Italy Department of Paediatrics and Child Health, University of Otago, Wellington, New Zealand Departments of Medicine and Paediatrics, University of Melbourne, Melbourne, Victoria, Australia Murdoch Children's Research Institute, Parkville, Victoria, Australia Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland |
Issue Date: | 2022 | Date: | 2022 | Publication information: | Epilepsia 2022; 63(4): 974-991 | Abstract: | Epilepsy is common in patients with PIGN diseases due to biallelic variants; however, limited epilepsy phenotyping data have been reported. We describe the epileptology of PIGN encephalopathy. We recruited patients with epilepsy due to biallelic PIGN variants and obtained clinical data regarding age at seizure onset/offset and semiology, development, medical history, examination, electroencephalogram, neuroimaging, and treatment. Seizure and epilepsy types were classified. Twenty six patients (13 female) from 26 families were identified, with mean age 7 years (range = 1 month to 21 years; three deceased). Abnormal development at seizure onset was present in 25 of 26. Developmental outcome was most frequently profound (14/26) or severe (11/26). Patients presented with focal motor (12/26), unknown onset motor (5/26), focal impaired awareness (1/26), absence (2/26), myoclonic (2/26), myoclonic-atonic (1/26), and generalized tonic-clonic (2/26) seizures. Twenty of 26 were classified as developmental and epileptic encephalopathy (DEE): 55% (11/20) focal DEE, 30% (6/20) generalized DEE, and 15% (3/20) combined DEE. Six had intellectual disability and epilepsy (ID+E): two generalized and four focal epilepsy. Mean age at seizure onset was 13 months (birth to 10 years), with a lower mean onset in DEE (7 months) compared with ID+E (33 months). Patients with DEE had drug-resistant epilepsy, compared to 4/6 ID+E patients, who were seizure-free. Hyperkinetic movement disorder occurred in 13 of 26 patients. Twenty-seven of 34 variants were novel. Variants were truncating (n = 7), intronic and predicted to affect splicing (n = 7), and missense or inframe indels (n = 20, of which 11 were predicted to affect splicing). Seven variants were recurrent, including p.Leu311Trp in 10 unrelated patients, nine with generalized seizures, accounting for nine of the 11 patients in this cohort with generalized seizures. PIGN encephalopathy is a complex autosomal recessive disorder associated with a wide spectrum of epilepsy phenotypes, typically with substantial profound to severe developmental impairment. | URI: | https://ahro.austin.org.au/austinjspui/handle/1/29955 | DOI: | 10.1111/epi.17173 | ORCID: | 0000-0003-4986-8006 0000-0002-6242-4306 0000-0001-9814-0324 0000-0001-5078-928X 0000-0002-7350-5136 0000-0002-5385-0119 0000-0002-6065-1476 0000-0001-7691-9492 0000-0002-9664-1448 0000-0002-5355-7115 0000-0003-2739-0515 0000-0002-2311-2174 |
Journal: | Epilepsia | PubMed URL: | 35179230 | PubMed URL: | https://pubmed.ncbi.nlm.nih.gov/35179230/ | Type: | Journal Article | Subjects: | GPI-anchoring disorder congenital disorder of glycosylation developmental and epileptic encephalopathy epilepsy intellectual disability |
Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.